Department of Dermatology

The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible? (2025) Arnet L, Emilius L, Hamann A, Carmo-Fonseca M, Berking C, Dörrie J, Schaft N Journal article NFATc1 in CD4+ T cells and CD11c+ dendritic cells drives TH2-mediated eosinophilic inflammation in allergic asthma (2025) Yang Z, Krammer S, Mitländer H, Grund J, Zirlik S, Wirtz S, Rauh M, et al. Journal article Engineering Therapeutic Regulatory T Cells to Overexpress G Protein-Coupled Receptor 15 Improves Functional Fitness for In Vivo Gut Homing (2025) Müller T, Liu L, Wiesinger M, Atreya I, Atreya R, Bacher P, Becker C, et al. Journal article, Letter Loading of CAR‐T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism (2025) Pfister F, Carnell L, Löffler L, Boosz P, Schaft N, Dörrie J, Stein R, et al. Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma (2025) Schaft N, Dörrie J Journal article, Review article A Network Biology-Guided Investigation of the Long Noncoding RNAs’ Role in Glaucoma (2025) Choudhari JK, Vera J, Chatterjee T Book chapter / Article in edited volumes A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia (2025) Suomela T, Zhang L, Vera J, Bruns H, Lai X Book chapter / Article in edited volumes Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article